skip to Main Content

Medicare (CMS) September 23rd 2018 Local Coverage Determination (LCD) Updates

Centers for Medicare & Medicaid Services (CMS) Local Coverage Determination (LCD) Updates »

September 23rd 2018 Medicare (CMS) LCD Updates:

  • L36408              Allergy Immunotherapy
  • L36402              Allergy Testing
  • DL37943           Anorectal Manometry and Electromyography (EMG) of the Urinary and Anal Sphincters
  • A54923             Bariatric Surgery for Treatment of Co-Morbidities Conditions Related to Morbid Obesity
  • A52370             Bevacizumab – Related to LCD L33394
  • DL37851           Biomarker Testing for Neuroendocrine Tumors/Neoplasms
  • L33944              Blepharoplasty
  • L34528              Blepharoplasty, Blepharoptosis and Brow Lift
  • L34635              Botulinum Toxin Type A & Type B
  • L33646              Botulinum Toxins
  • L33949              Botulinum Toxins
  • A52849             Breast Imaging: Breast Echography (Sonography)/Breast MRI/Ductography – Supplemental Instructions Article
  • L33959              Cardiac Catheterization and Coronary Angiography
  • L33952              Cardiac Event Detection
  • A55639             Chemotherapy Agents for Non-Oncologic Conditions
  • L34093              Chemotherapy and Biologicals
  • L34585              Chiropractic Services
  • L34005              Colonoscopy/Sigmoidoscopy/Proctosigmoidoscopy
  • L33562              Computed Tomographic (CT) Colonography for Diagnostic Uses
  • L36029              Controlled Substance Monitoring and Drugs of Abuse Testing
  • L34032              Debridement Services
  • L34645              Drug Testing
  • L33667              Duplex Scan Of Lower Extremity Arteries
  • A56131             Duplex scan of lower extremity arteries revision to the Part A and Part B LCD
  • L34633              Erythropoiesis Stimulating Agents (ESAs)
  • L34037              Flow Cytometry
  • L34651              Flow Cytometry
  • DL37810           Genomic Sequence Analysis Panels in the Treatment of Solid Organ Neoplasm
  • L33431              HbA1c
  • A52434             Health and Behavior Assessment/Intervention – Medical Policy Article
  • L33785              High Frequency Chest Wall Oscillation Devices
  • L34561              Home Health – Psychiatric Care
  • L34699              Human Granulocyte/Macrophage Colony Stimulating Factors
  • A52936 (retired) Humanitarian Use Devices and Exemptions (HUDs and HDEs)
  • L33563              Incision and Drainage (I & D) of Abscess of Skin, Subcutaneous and Accessory Structures
  • L34623              Intraoperative Neurophysiological Testing
  • A52447             Laparoscopic Sleeve Gastrectomy (LSG) – Medical Policy Article
  • L33795              Mechanical In-exsufflation Devices
  • L35494              Mohs Micrographic Surgery
  • A54376             MolDX: Avise PG Assay Billing and Coding Guidelines
  • A54378             MolDX: Avise PG Assay Billing and Coding Guidelines
  • A55144             MolDX: Avise PG Assay Billing/Coding Update
  • L36139              MolDX: Biomarkers in Cardiovascular Risk Assessment
  • L36523              MolDX: Biomarkers in Cardiovascular Risk Assessment
  • L36813              MolDX: BRCA1 and BRCA2 Genetic Testing
  • L37787              MolDX: Corus® CAD Assay
  • DL37891           MolDX: Envisia, Veracyte, Idiopathic Pulmonary Fibrosis Diagnostic Test
  • A55161             MolDX: FDA-Approved BRAF Tests
  • L36815              MolDX: Genetic Testing for BCR-ABL Negative Myeloproliferative Disease
  • L36398              MolDX: Genetic Testing for CYP2C19, CYP2D6, CYP2C9, and VKORC1
  • L36153              MolDX: Genomic Health™ Oncotype DX® Prostate Cancer Assay
  • L36789              MolDX: Genomic Health™ Oncotype DX® Prostate Cancer Assay
  • L37671              MolDX: Guardant360® Plasma-Based Comprehensive Genomic Profiling in Non-Small Cell Lung Cancer (NSCLC)
  • DL37899           MolDX: Inivata, InVisionFirst, Liquid Biopsy for Patients with Lung Cancer
  • L36807              MolDX: Molecular Diagnostic Tests (MDT)
  • L36795              MolDX: Molecular RBC Phenotyping
  • L37713              MolDX: Multiplex Nucleic Acid Amplified Tests for Respiratory Viral Panels
  • A55224             MolDX: Myriad’s BRACAnalysis CDx® Coding and Billing Guidelines
  • L36941              MolDX: Oncotype DX® Breast Cancer for DCIS (Genomic Health™)
  • L36947              MolDX: Oncotype DX® Breast Cancer for DCIS (Genomic Health™)
  • L37199              MolDX: Oncotype DX® Breast Cancer for DCIS (Genomic Health™)
  • L36787              MolDX: Prolaris™ Prostate Cancer Genomic Assay
  • L35000              Molecular Pathology Procedures
  • L34594              Nerve Conduction Studies and Electromyography
  • A54862             Nivolumab – Related to LCD L33394
  • L35998              Non-Coronary Vascular Stents
  • L34555              Non-Covered Category III CPT Codes
  • L35753              Non-Invasive Cerebrovascular Studies
  • L35751              Non-Invasive Peripheral Venous Vascular and Hemodialysis Access Studies
  • L33627              Non-Invasive Vascular Studies
  • L34045              Non-Invasive Vascular Studies
  • A52479             Oral Anticancer Drugs – Policy Article
  • A52480             Oral Antiemetic Drugs (Replacement for Intravenous Antiemetics) – Policy Article
  • L34353              Outpatient Psychiatry and Psychology Services
  • A52450             Paclitaxel (e.g., Taxol®/Abraxane ™) – Related to LCD L33394
  • L33622              Pain Management
  • L36850              Peripheral Nerve Blocks
  • L35075              Proton Beam Therapy
  • L36658              Proton Beam Therapy
  • L33624              Psychiatric Inpatient Hospitalization
  • L33626              Psychiatric Partial Hospitalization Programs
  • L33632              Psychiatry and Psychology Services
  • L34616              Psychiatry and Psychology Services
  • L34200              Removal of Benign Skin Lesions
  • L35498              Removal of Benign Skin Lesions
  • A56142             Response to Comments: MolDX: Corus® CAD Assay
  • A56140             Response to Comments: MolDX: Multiplex Nucleic Acid Amplified Tests for Respiratory Viral Panels
  • L34246              Routine Foot Care and Debridement of Nails
  • L34061              Scanning Computerized Ophthalmic Diagnostic Imaging (SCODI)
  • L34624              Somatosensory Testing
  • L35906              Somatosensory Testing
  • L36805              Special Histochemical Stains and Immunohistochemical Stains
  • A52879             Stem Cell Transplantation – Medical Policy Article
  • L35076              Stereotactic Radiation Therapy: Stereotactic Radiosurgery (SRS) and Stereotactic Body Radiation Therapy (SBRT)
  • L34084              Transcatheter Infusion Therapy
  • L34337              Transesophageal Echocardiography (TEE)
  • L33578              Transrectal Ultrasound
  • DL37929           Transvenous Phrenic Nerve Stimulation in the Treatment of Central Sleep Apnea
  • L34536              Treatment of Varicose Veins of the Lower Extremities
  • L34588              Trigger Points, Local Injections
  • L36037              Urine Drug Testing
  • L33576              Urodynamics
  • L34615              Visual Fields
  • L33574              Visual Fields Testing
  • L34658              Vitamin D Assay Testing
  • L37535              Vitamin D Assay Testing
  • L33312              Wheelchair Seating
  • A55909             Wound Care Coding Companion for Wound Care


Centers for Medicare & Medicaid Services (CMS) Local Coverage Determination (LCD) Updates »


Policy Alerts monitors Commercial and Medicare medical policies for changes. While medical Insurance carriers typically update medical policies annually, there are many reasons why they might review or update a policy. When reviews occur out of cycle they often go unnoticed. Policy Alerts keeps you updated when Payers make coverage changes to medical policies affecting your business.

Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on medical Insurance decisions in real-time. When changes occur, instant email alerts are delivered to your inbox. Clients have access to detailed coverage reports and medical policies through the interactive Policy Alerts Dashboard portal. Save time each month and keep focused on important Payer medical policy reviews and coverage decisions affecting your business!

Policy Alerts takes a client-focused hands-on approach and is constantly working to provide our customers with helpful insights and actionable analytics. We understand what our clients need and are dedicated to providing timely, accurate, and always up-to-date reports.

Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.

This Post Has 0 Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

Back To Top